Search Press releases

9 Aug 2024

Transparency notification Goldman Sachs

Read More
8 Aug 2024

Transparency notification Goldman Sachs

Read More
7 Aug 2024

Transparency notification Goldman Sachs

Read More
5 Aug 2024

UCB announces European Commission approval for 320 mg device presentations of BIMZELX[®]▼(bimekizumab)

Read More
25 Jul 2024

Strong Start into UCB’s Decade of Growth

Read More
28 Jun 2024

Acquisition of own shares

Read More

Stay up-to-date on the latest news and information from UCB